| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 8, 2014Advanced Illumina™ 3D Programming Software Provides Highly Significant Pain Relief in Study Patients
New retrospective data highlighting the Boston Scientific Corporation (NYSE: BSX) Precision Spectra™ Spinal Cord Stimulator (SCS) System demonstrate the device provided sustained and highly...
-
Apr 24, 2014Nel 2013 aumentati più del 50% gli impianti di “ombrellini salvacuore”che riducono il rischio ictus del 77%
Milano, 23 Aprile 2014 - Ogni anno, in Italia, 200mila persone vengono colpite da ictus, con un impatto pesantissimo sulle famiglie, sia dal punto di vista sociale che economico. Si stima che nel...
-
Apr 10, 2014Study to Evaluate Clinical Outcomes and Economic Value of the Vercise™ Deep Brain Stimulation (DBS) System
Boston Scientific Corporation (NYSE: BSX) has enrolled the first patient in a new registry to evaluate clinical outcomes and the economic value of the Vercise™ Deep Brain Stimulation (DBS)...
-
Apr 2, 2014These and Other Studies Reinforce Global Commitment to the Development of Innovative Therapies to Improve Care for Patients with Cardiovascular Disease
Reinforcing its position as a global leader in bringing new therapies to patients with heart and cardiovascular disease, Boston Scientific Corporation (NYSE: BSX) reported favorable results in...
-
Feb 24, 2014Dystonia Europe (DE) and The European Parkinson’s Disease Association (EPDA) announced today that they are collaborating with Boston Scientific Corporation (NYSE:BSX), a global medical technology leader. The aim of these partnerships is to increase awareness, understanding of solutions and to take initiatives in the worldwide fight against Parkinson’s disease and dystonia, two areas of high unmet need.
Both Parkinson’s and dystonia are neurological diseases which include involuntary body movements such as tremors, sustained muscle contractions and abnormal twisting or postures, often referred...
-
Dec 6, 2013New Retrospective Data Presented at NANS 2013 Show Highly Significant Reduction in Pain and High Trial Therapy Success Rate of Precision Spectra in the Treatment of Chronic Pain
New retrospective data highlighting the Boston Scientific Corporation (NYSE: BSX) Precision Spectra™ Spinal Cord Stimulator (SCS) System demonstrate the device provided highly significant pain...
-
Oct 28, 2013REDUCE-HTN Data Presented Today at TCT Demonstrate Excellent Safety Profile
Patients treated with the Boston Scientific (NYSE: BSX) Vessix™ Renal Denervation System experienced a significant and sustained reduction in blood pressure, according to new data presented...
-
Oct 28, 2013Il dispositivo per la sostituzione transcatetere della valvola aortica (TAVR, Transcatheter Aortic Valve Replacement) permette il posizionamento preciso, garantendo ai medici una possibilità di controllo senza precedenti
Boston Scientific Corporation (NYSE: BSX) ha ricevuto il marchio CE per la valvola Lotus™, la tecnologia innovativa d e ll'azienda per la sostituzione transcatetere della valvola aortica (TAVR)....
-
Sep 25, 2013Boston Scientific comunica i risultati positivi a sei mesi dello studio clinico sulla valvola Lotus™I dati di REPRISE II premiati con il Miglior Abstract 2013 al PCR London Valves Course
La Boston Scientific Corporation (NYSE: BSX) ha comunicato i risultati positivi a sei mesi dei primi 60 pazienti arruolati nello studio clinico REPRISE II che valutava la sicurezza e la...
-
Sep 9, 2013I benefici comportati dalla termoplastica bronchiale perdurano per anni, anziché per ore, diversamente da quanto accade col solo trattamento farmacologico.
News Newsroom Italia Asma grave Archivio Comunicati Stampa 2013 Sep 09, 2013 Comunicato Stampa The Journal of Allergy and Clinical Immunology pubblica i dati sulla termoplastica bronchiale che...